- Experimental Treatment of Hepatocellular Carcinoma
-
Choi JY
- KMID: 772764
- Korean J Gastroenterol.
- 2005 Apr;45(4):271-276.
Hepatocellular carcinoma (HCC) is one of the most common malignancies world wide. Several experimental treatments have been tested against HCC. Those are chemotherapy, high dose proton beam radiotherapy, external beam... -
- CITED
-
- Close
- SHARE
-
- Close
- Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future
-
Woo HY, Heo J
- KMID: 2359814
- Clin Mol Hepatol.
- 2015 Dec;21(4):344-348.
- doi: 10.3350/cmh.2015.21.4.344
Transarterial chemoembolization (TACE) using doxorubicin-eluting beads (DEBs) have been introduced as a novel device which ensures more sustained and tumor-selective drug delivery and permanent embolization compared to conventional TACE with... -
- CITED
-
- Close
- SHARE
-
- Close
- Radioembolization for the treatment of hepatocellular carcinoma
-
Kim HC
- KMID: 2413112
- Clin Mol Hepatol.
- 2017 Jun;23(2):109-114.
- doi: 10.3350/cmh.2017.0004
Transarterial radioembolization (TARE) with yttrium 90 (â¹â°Y), an intra-arterial procedure performed by interventional radiologists, has begun being utilized in managing hepatocellular carcinoma (HCC) in Korea. There are two available TARE... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Resection of Biloma with Hepatocellular Carcinoma after Embolization.
-
Park WK, Chang JC, Lee HZ, Kim HJ, Choi JH, Gu MJ
- KMID: 863106
- Korean J Hepatol.
- 2002 Sep;8(3):331-335.
Intrahepatic biloma is one of the rare complications occurring after transcatheter arterial chemoembolization (TACE). Biloma after TACE may result from the development of peripheral bile duct necrosis caused by... -
- CITED
-
- Close
- SHARE
-
- Close
- The Current Practice of Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma
-
Shin SW
- KMID: 1093956
- Korean J Radiol.
- 2009 Oct;10(5):425-434.
- doi: 10.3348/kjr.2009.10.5.425
Despite remarkable advancement in the surveillance and treatment of hepatocellular carcinoma (HCC) and the availability of novel curative options, a great proportion of HCC patients are still not eligible for... -
- CITED
-
- Close
- SHARE
-
- Close
- Practice Guideline for Diagnosis and Treatment of Hepatocellular Carcinoma
-
Park JW
- KMID: 760536
- Korean J Hepatol.
- 2004 Jun;10(2):88-98.
BACKGROUND/AIMS: Hepatocellular carcinoma (HCC) is the 3rd most common cancer. The annual incidence is over 10,000 cases in Korea. While hepatitis B virus is major cause of Korean HCC,... -
- CITED
-
- Close
- SHARE
-
- Close
- A case of hepatocellular carcinoma in the caudate lobe successfully treated by transcatheter arterial chemoembolization using drug-eluting beads
-
Joh DH, Kim JD, Kim YN, Song HH, Kim H, Song KH, Lee SJ, Lee JR, Jeon WJ, Cha BH
- KMID: 1117699
- Korean J Hepatol.
- 2010 Dec;16(4):405-409.
- doi: 10.3350/kjhep.2010.16.4.405
Hepatocellular carcinoma (HCC) in the caudate lobe remains one of the most intricate locations where various treatments tend to pose problems with regard to the optimal approach. Surgical resection has... -
- CITED
-
- Close
- SHARE
-
- Close
- Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization
-
Yoo SH, Jang JW, Kwon JH, Jung SM, Jang B, Choi JY
- KMID: 2373150
- Clin Mol Hepatol.
- 2016 Dec;22(4):458-465.
- doi: 10.3350/cmh.2016.0054
BACKGROUND/AIMS: Hepatic damage during transarterial chemoembolization (TACE) is a critical complication in patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). Apart from its role in preventing HBV reactivation, there... -
- CITED
-
- Close
- SHARE
-
- Close
